Drug for preventing and/or treating brain tumor and application thereof
AssigneeCAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
InventorsZhu Tao, Wenting Ding, Zhipeng Cheng, Yinfang Feng, Li Qin, Xiaoping Chen
Life of this patent
Estimating the term…
Abstract
A drug for preventing and/or treating a brain tumor and an application thereof. The drug comprises plasmodium. The drug has significant preventive and/or therapeutic effects on a brain tumor. The drug mainly regulates the immunological functions and inflammation-related factors of the body to break through the blood-brain barrier by fully activating immunocompetence and inhibiting the growth of a brain tumor, thereby extending lifespan.
Claims11
A drug for preventing and/or treating brain tumors, wherein the drug comprises at least one Plasmodium strain;
- wherein the brain tumors are primary brain tumors or metastatic brain tumors;
- wherein the Plasmodium strain is cryopreserved and resuscitated Plasmodium strain;
- wherein the cryopreserved and resuscitated comprises the following steps:
- (1) cryopreservation of Plasmodium;
- (1.1) centrifuging whole blood containing Plasmodium at 300×g for 5 minutes, and transferring plasma to another 50 mL centrifuge tube;
- (1.2) removing leukocyte layer, and adding 2 volumes of 1640 culture medium, mixing well and centrifuging at 300×g for 5 minutes;
- (1.3) dropping an equal volume of 28% glycerol cryopreservation solution slowly into the 50 mL centrifuge tube, shaking and mixing well while adding, and incubating at room temperature for 5 minutes;
- (1.4) packing a RBC-glycerol cryopreservation solution mixture separately in cryopreservation tubes, 1.0 mL per tube;
- (1.5) putting the cryopreservation tubes into a cryopreservation box and directly storing the cryopreservation box into liquid nitrogen;
- (1.6) performing quality control by adding a proper amount of the RBC-glycerol cryopreservation solution mixture before cryopreservation to a proper amount of RPMI 1640 culture medium, culturing in an incubator with CO2 at 37° C. for 72 hours, and observing the color of the culture medium to confirm absence of turbidity;
- (2) resuscitation of Plasmodium;
- (2.1) preparing a 37° C. water bath cauldron, 50 mL centrifuge tubes, 3.5% NaCl solution, sodium chloride injection, a centrifuge, printed labels, and forms;
- (2.2) checking labels of cryopreservation tubes;
- (2.3) taking a cryopreserved Plasmodium blood and bath in water at 37° C. for 1 to 3 minutes, mixing well quickly and thawing;
- (2.4) transferring the cryopreserved Plasmodium blood to a 15 mL centrifuge tube, adding an equal volume of 3.5% NaCl solution slowly along the tube wall, pipetting gently and mixing well, standing at room temperature for 5 minutes, and discarding a supernatant;
- (2.5) adding 5 volumes of 0.9% NaCl solution along the tube wall, pipetting gently and mixing well, centrifuging at 300×g for 5 minutes, and discarding a supernatant;
- (2.6) adding normal saline to achieve 50% hematocrit, mixing well, counting and recording red blood cells density, and storing temporarily at 4° C. for clinical inoculation;
- (2.7) performing quality control by smearing remaining blood samples, preparing blood smears, and observing parasitemia and Plasmodium status via microscopy before injection, and recording.
Dependencies are inferred from the claim text.